SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-127654
Filing Date
2024-05-01
Accepted
2024-05-01 17:24:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d826339d424b5.htm 424B5 505590
2 GRAPHIC g826339g00g03.jpg GRAPHIC 62704
3 GRAPHIC g826339g01g01.jpg GRAPHIC 33879
4 GRAPHIC g826339g40g40.jpg GRAPHIC 39214
  Complete submission text file 0001193125-24-127654.txt   687043
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265470 | Film No.: 24904207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)